Navigation Links
Drug developed by Hebrew U. and others holds promise for treatment of wounds
Date:2/16/2011

Jerusalem, February 7, 2011 -- A low cost, nanometer-sized drug to treat chronic wounds, such as diabetic foot ulcers or burns, has been developed by a group of scientists from the Hebrew University of Jerusalem, Harvard Medical School and others in the U.S. and Japan.

Diabetes is a rapidly growing medical problem affecting close to 3 percent of the world's population. Poor blood circulation arising from diabetes often results in skin wounds which do not heal, causing pain, infection and at times amputation of limbs.

Several proteins, called growth factors, have been found to speed up the healing process, however purifying these growth factor proteins is very expensive, and they do not last long on the injured site.

Now, scientists at the Hebrew University and Harvard involved in the project have used genetic engineering to produce a "robotic" growth factor protein that responds to temperature. Increasing the temperature causes dozens of these proteins to fold together into a nanoparticle that is more than 200 times smaller than a single hair.

This behavior greatly simplifies protein purification, making it very inexpensive to produce. It also enables the growth factor to be confined and to remain at the burn or wound site. The scientists refer to their discovery as robotic, since just as robots are machines that respond to their environment by carrying out a specific activity, so too this protein they have developed responds and reacts to heat.

The experimental drug, which ha been developed by the research group as a topical ointment, has been patented and thus far has been used to treat chronic wounds in diabetic mice, dramatically increasing the healing rate. The goal is to proceed to human clinical trials at some future date after future tests and refinements.


'/>"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-258-82904
The Hebrew University of Jerusalem
Source:Eurekalert  

Page: 1

Related biology technology :

1. Human Trial Results Show Plant Extract Tops Drug at Regulating Blood Sugar Levels; Huge Market Seen for Newly Developed Food Additive Emulin™
2. FDA Approves Clinical Studies of a Novel Anti-Cancer Drug Developed by Italian Researchers
3. Designer molecules being developed to fight disease
4. SAFC Supply Solutions(R) Announces Raw Materials Line Developed Specifically to Meet Molecular Diagnostics Manufacturing Requirements
5. New Sigma Advanced Genetic Engineering Labs Offers Research Community Unique Rodent Models Developed Using Exclusive Gene-Editing Technology
6. QIAGENs New Product Line, QIAsafe(R) DNA Blood, has Been Co-Developed With Biomatrica and is Based on Biomatricas SampleMatrix(R) Technology
7. NovaBay(R) Presents Data Confirming Its Aganocide(R) Compounds Are Effective In Killing Bacteria That Have Developed Multidrug-Resistance
8. New lab-on-a-chip technique developed at U of T
9. New nanotech sensor developed with medical, chemistry applications
10. New Program Developed in the Fight Against Feline Aids
11. DuPont Leader: Drought-Tolerant Crops Developed Through Modern Breeding are Key to Sustainably Increasing Grain Production
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug developed by Hebrew U. and others holds promise for treatment of wounds
(Date:2/26/2015)... SAN FRANCISCO, Calif. , Feb. 26, 2015 /PRNewswire/ ... the treatment of cancer, today announced that Sean ... a corporate overview at the upcoming Cowen and Company ... Boston . Dr. McCarthy,s presentation will take ... About CytomX Therapeutics CytomX Therapeutics develops ...
(Date:2/26/2015)... , Feb. 26, 2015 Caris ... posters, at the 2015 Genitourinary Cancers Symposium in ... the clinical utility of tumor profiling. Both studies ... tumor profiling service, to identify biomarkers that shed ... cancer and small cell bladder cancer (SCBC). ...
(Date:2/25/2015)... EDMONTON , Feb. 25, 2015 /CNW/ - Radient Technologies ... has released its financial results for the third quarter ... unaudited financial statements, Management,s Discussion and Analysis, and the ... month periods ended December 31, 2014 are available on ... and Interim CFO Appointment The Corporation is also pleased ...
(Date:2/25/2015)... Today, BioMed Realty Trust, Inc. (NYSE: ... of promotions and additions to its leadership team focused ... shareholder returns through strategic investments in real estate at ... the innovation sector. The company also ... leaving his role as President and Chief Operating Officer ...
Breaking Biology Technology:Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 3Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 4Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 5Radient Technologies Inc. Releases Third Quarter Results and Appoints New Interim CFO 2BioMed Realty Announces Realignment To Leverage Depth Of Life Science Real Estate Expertise And Increase Shareholder Value 2BioMed Realty Announces Realignment To Leverage Depth Of Life Science Real Estate Expertise And Increase Shareholder Value 3BioMed Realty Announces Realignment To Leverage Depth Of Life Science Real Estate Expertise And Increase Shareholder Value 4
... Study Recruiting Adult Parkinson,s Patients with Behavioral Changes ... 22 Parkinson,s disease affects 6.3 million people worldwide. ... on movement such as tremors, less known is that ... that include hallucinations, illusions and delusions. ACADIA Pharmaceuticals, a ...
... Company,s groundbreaking products are featured in Genetic Engineering News for delivering ... ... Fort Collins, CO (PRWEB) January 22, 2009 -- InVitria,s ... Genetic Engineering News (GEN, Jan 15, 2009 pp 32-34). The article, ...
... company Lytix Biopharma today announced the closure of a,successful ... NOK (US$ 10.4,million), the proceeds of which will fund ... Lytix develops novel lytic peptide drugs ... well as first-in-class oncology,treatments - both areas with high ...
Cached Biology Technology:Clinical Research Study Focuses on Little Known Behavioral Changes Related to Parkinson's Disease 2InVitria Among Leading Innovators in Cell Culture Media According to Top Biotechnology Publication 2Lytix Closes USD 10.4 Million Funding Round 2
(Date:2/25/2015)... 25, 2015  ABC Financial Services (ABC), the ... Health and Fitness Industry, today announced enhancements to ... The latest upgrade includes advances to the agreement ... check-in via Identity One fingerprint biometrics. The features ... interactive displays at the International Health, Racquet & ...
(Date:2/24/2015)... This report analyzes the worldwide markets for Iris Biometrics in ... US, Canada , Japan ... , Middle East , and ... for the period 2013 through 2020. Also, a seven-year historic ... are derived from primary and secondary research. Company profiles are ...
(Date:2/24/2015)... report analyzes the worldwide markets for Face and Voice Biometrics in ... The report provides separate comprehensive analytics for the US, ... , Asia-Pacific , Middle East ... Latin America . Annual estimates and forecasts are provided for ... provided for these markets. Market data and analytics are derived from ...
Breaking Biology News(10 mins):ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16
... and how scientists should inform participants in genomic studies ... aim of new research funded with a $5.7 million ... and director of the Center for Biomedical Ethics and ... "These new research projects will help us understand how ...
... corals and appear healthy may, in fact, be heading toward ... Society and other groups. Using data from coral ... of researchers identified how overfishing creates a series of at ... collapse. This information can help managers gauge the health of ...
... Institute at St. Joseph,s Hospital and Medical Center have identified ... that represents potential targets of brain injuries affecting newborns. The ... evolves, is published in the current issue of Nature ... Nader Sanai, MD, director of Barrow,s Brain Tumor Research ...
Cached Biology News:Vanderbilt ethicist to study return of results issue involving children in genomics studies 2Wildlife Conservation Society study uncovers a predictable sequence toward coral reef collapse 2Wildlife Conservation Society study uncovers a predictable sequence toward coral reef collapse 3Barrow scientists identify new stem cell activity in human brain 2
... starter kit is intended for first-time users of ... The kit includes a protein sample and reagents ... gels six 17 cm, ten 11 cm, or ... strips and precast SDS-PAGE gels and gels stains ...
... Immunogen : Fusion protein corresponding ... of human Mi-2 Formulation: 0.7M ... 0.035% sodium azide, containing 30% ... by immunoblot on Hela nuclear ...
Anti-CaM kinase II recognizes the enzymes a subunit (6) and reacts with tissue from all mammalian species tested, as well as with chicken and frog tissues....
... to Synaptogyrin 2 ( Abpromise ... Antigen: ... Internal sequence amino acids 42-57 ... Entrez Gene ID: ...
Biology Products: